Automated cardiopulmonary resuscitation or CPR devices are medical equipment used to perform chest compressions during cardiac arrests. It helps maintain blood circulation to vital organs like the brain until the victim can receive medical help. Such devices utilize a piston or suction cup to compress the chest at consistent depths and rates as recommended by resuscitation guidelines. They are often utilized in emergency vehicles, public places, hospitals, and other locations where multiple victims may need assistance simultaneously. The devices remove human error and reduce rescuer fatigue allowing for high-quality, consistent CPR.

The global automated CPR devices market is estimated to be valued at US$ 127.06 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The growing prevalence of cardiovascular diseases and cardiac arrests is a major driver boosting the automated CPR devices market. As per the World Health Organization’s latest data, cardiovascular diseases account for over 17 million deaths globally every year, with nearly half of those due to heart attacks. Since early and effective CPR can significantly improve survival rates during cardiac arrests, automated devices ensure timely and accurate resuscitation. Additionally, ongoing technological advancements are helping manufacturers introduce more innovative products with enhanced features. For example, some new devices can automatically provide real-time audio and visual feedback on compression depth and rate to the rescuer, thereby optimizing treatment quality. Such developments are expected to further support market growth over the forecast period.

SWOT Analysis
Strength: Automated CPR devices provide consistent, high-quality chest compressions that match guidelines for rate and depth. They can perform compressions for longer durations without tiring like human users might. Automated devices also provide objective data on compression rate, depth, recoil that helps in resuscitation efforts.

Weakness: Automated CPR devices are expensive to purchase and maintain. They also require regular replacement of parts which increases the cost of ownership. Storage and transport of automated devices can also be challenging given their bulk and weight.

Opportunity: Rising incidence of cardiac arrests globally is expected to drive the demand for automated CPR devices. Their use can help standardize rescue efforts and potentially improve clinical outcomes. Growing focus on public-access defibrillation programs can promote usage of automated devices in public places.

Threats: Preference for conventional manual CPR by some healthcare professionals can limit adoption. Lack of reimbursement policies for automated devices in many regions poses a challenge. Stringent regulatory approvals also delay market entry of new players.


Key Takeaways
The global automated CPR devices market size is expected to witness high growth. The market size is forecast to reach US$ 127.06 million by 2024, registering a CAGR of over 10% during the forecast period.

Regional analysis: North America currently dominates the global market owing to presence of supportive reimbursement policies and growing focus on public-access defibrillation programs in the region. Asia Pacific is expected to be the fastest growing market owing to improving healthcare infrastructure, rising medical tourism, and increasing incidence of cardiac arrests.

Key players: Key players operating in the automated CPR devices market are AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.

Get more insights on this topic: https://www.newsstatix.com/automated-cpr-devices-market-industry-insights-trends-automated-cpr-devices-market/